1. BiotechMaster BiotechMaster

    At least $CYTK has sugar daddie $AMGN helping out. Should get a nice milestone payment soon.

    stocktwits 5 hours 6 minutes ago

  2. BiotechMaster BiotechMaster

    All microcap biotechs, $CYTK included, have terrible finances. It is the nature of the beast. Microcap biotechs expenses>>revenue. Always.

    stocktwits 5 hours 8 minutes ago

  3. BiotechMaster BiotechMaster

    If Ome succeeds, $CYTK will do well r/s or no r/s. If Ome fails, $CYTK will tank r/s or no r/s. Simple.

    stocktwits 5 hours 9 minutes ago

  4. BiotechMaster BiotechMaster

    $CYTK Like all microcap biotechs, success will depend upon success of drugs in their pipeline, R/S or not.

    stocktwits 5 hours 10 minutes ago

  5. BiotechMaster BiotechMaster

    If $CYTK >$5, then large investors/mutual funds can buy stock.

    stocktwits 5 hours 12 minutes ago

  6. BiotechMaster BiotechMaster

    $CYTK Should be an interesting meeting today. Would place odds of R/S at 50:50. If they do, they should do at least a 5:1.

    stocktwits 5 hours 13 minutes ago

  7. BiotechMaster BiotechMaster

    $CYTK Relaxin preps the body for childbirth: loosens up joints/ligaments. In older people, would cause more falls/fractures/metastatic CA.

    stocktwits 9 hours 21 minutes ago

  8. BiotechMaster BiotechMaster

    $CYTK Much focus on relaxin, which is a joke. There is a reason 70-year old women do not give birth: their bodies cannot tolerate it.

    stocktwits 9 hours 23 minutes ago

  9. BiotechMaster BiotechMaster

    $CYTK Omecam superior to relaxin, ularitide, clevidipine, levosimendan. Others DO NOT increase efficiency of heart like Omecam. IMHO

    stocktwits 9 hours 27 minutes ago

  10. BiotechMaster BiotechMaster

    $CYTK Omecam is the most promising heart failure drug currently in development. Period. Increases EF/SV/CO. Decreases HR/BP. No arrhythmias.

    stocktwits 9 hours 30 minutes ago

  11. BiotechMaster BiotechMaster

    $CYTK Usually give multiple talks if large, late phase (P3) study.

    stocktwits 9 hours 37 minutes ago

  12. BiotechMaster BiotechMaster

    $CYTK Usually, just have one poster and one talk. Funny they will give 3 talks. Do not want to present same data 3 times. Curious.

    stocktwits 9 hours 41 minutes ago

  13. BiotechMaster BiotechMaster

    Info on Omecamtiv presentations on Heart Failure Congress 2013 website. Interesting $CYTK will give THREE talks on Ome.

    stocktwits 9 hours 44 minutes ago

  14. BiotechMaster BiotechMaster

    @jamesdyer $CYTK You can find info on Heart Failure Congress 2013 website

    stocktwits 9 hours 45 minutes ago

  15. BiotechMaster BiotechMaster

    $CYTK Will have 3 talks,1 poster session @ Euro cardio meeting May 26-27. Would be perfect if they present new P2b ATOMIC data.

    stocktwits 11 hours 24 minutes ago

  16. Macroeconomics Macroeconomics

    @Rogue1 Whatever it is... Hopefully, it causes some movement in the price. Undervalued right now... Needs to move up. $CYTK

    stocktwits 11 hours 51 minutes ago

  17. Rogue1 Rogue1

    $CYTK Annual meeting is tomorrow @ 1:30pm pacific. Update on Ome?

    stocktwits 18 hours 15 minutes ago

  18. Rogue1 Rogue1

    @Macroeconomics It has to wait till my profits from solars settle, so I can add while it runs up. In other words, 3+ days. ;-) $cytk

    stocktwits 19 hours 29 minutes ago

  19. Macroeconomics Macroeconomics

    $CYTK has been quiet for a while. When is this thing moving back to $1.40

    stocktwits 21 hours 51 minutes ago

  20. Keynesonomics Keynesonomics

    $CYTK could receive as much as $300 mil in milestones PRIOR to launch & an equal amount following launch.Payments r inevitable catalysts

    stocktwits Mon May 20, 2013 11:46 pm EDT

  21. BiotechMaster BiotechMaster

    $AMGN is listening to $CYTK s story/research platform, Wall St is not. If Ome succeeds, $CYTK will become a perfect $AMGN takeover target

    stocktwits Mon May 20, 2013 11:34 pm EDT

  22. BiotechMaster BiotechMaster

    $CYTK Omecamtiv is the most promising heart failure drug in decades. Only drug that goes after root cause of HF, not just treat symptoms.

    stocktwits Mon May 20, 2013 11:21 pm EDT

  23. BiotechMaster BiotechMaster

    $CYTK Omecamtiv could be the miracle drug that heart failure patients have been waiting for. Improved SOB, improved walking. No surgery.

    stocktwits Mon May 20, 2013 11:15 pm EDT

  24. BiotechMaster BiotechMaster

    $AMGN knows the tremendous potential of $CYTK s Omecamtiv. Why else would they sign a huge $600M+royalties agreement with tiny $CYTK?!

    stocktwits Mon May 20, 2013 11:12 pm EDT

  25. kgpittm kgpittm

    $PPHM $STP $USLV $COOL $SUPN $SVM - yeah, I d say I m pretty happy today :D - $ONTY, $CYTK, $ALXA, $SKUL can join party soon

    stocktwits Mon May 20, 2013 12:12 pm EDT

More messages